Technology

INTRAGEL’s novel technology features a pre-filled ready to use syringe which is for direct intra-tumoral application. The syringe contains an anti-cancer drug formulated into a de-novo gel-like, hydrophobic, biocompatible and biodegradable polymer that slowly releases the drug into the tumor over a few weeks with minimal systemic toxicity and maximum safety.

• INTRAGEL’s technology can be applied to a wide range of anti-cancer drugs and is suitable for various types of solid tumors.

• INTRAGEL’s technology is protected by a patent application.

• INTRAGEL has so-far achieved excellent pre-clinical results.